Evidence map›Paper›PMID 39149253›Full record

ArticlebioRxiv : the preprint server for biology2024

Multiscale heterogeneity of white matter morphometry in psychiatric disorders.

Ashlea Segal, Robert E Smith, Sidhant Chopra, Stuart Oldham, Linden Parkes, Kevin Aquino, Seyed Mostafa Kia, Thomas Wolfers, Barbara Franke, Martine Hoogman and 17 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors.

Ashlea SegalTurner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Melbourne, Australia.ORCID 0000-0002-7451-6195
Robert E SmithThe Florey Institute of Neuroscience and Mental Health, Heidelberg, Victoria, Australia.ORCID 0000-0003-3636-4642
Sidhant ChopraDepartment of Psychology, Yale University, New Haven, CT, USA.ORCID 0000-0003-0866-3477
Stuart OldhamTurner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Melbourne, Australia.ORCID 0000-0002-9619-6102
Linden ParkesDepartment of Psychiatry, Rutgers University, Piscataway, NJ 08854, USA.ORCID 0000-0002-9329-7207
Kevin AquinoBrainKey Inc, Palo alto, USA.ORCID 0000-0002-7435-0236
Seyed Mostafa KiaDonders Centre for Cognitive Neuroimaging, Radboud University, Nijmegen, the Netherlands.ORCID 0000-0002-7128-814X
Thomas WolfersDonders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands.ORCID 0000-0002-7693-0621
Barbara FrankeDepartment of Cognitive Neuroscience, Donders Institute of Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.ORCID 0000-0003-4375-6572
Martine HoogmanDepartment of Human Genetics, Donders Institute of Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.ORCID 0000-0002-1261-7628
Christian F BeckmannDonders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands.ORCID 0000-0002-3373-3193
Lars T WestlyeNorwegian Centre for Mental Disorders Research (NORMENT), Division of Mental Health and Addiction, University of Oslo & Oslo University Hospital, Oslo, Norway.ORCID 0000-0001-8644-956X
Ole A AndreassenDepartment of Psychology, University of Oslo, Oslo, Norway.ORCID 0000-0002-4461-3568
Andrew ZaleskyMelbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne, Victoria, Australia.
Ben J HarrisonDepartment of Psychiatry, The University of Melbourne, Victoria, Australia.
Christopher G DaveyDepartment of Psychiatry, The University of Melbourne, Victoria, Australia.ORCID 0000-0003-1431-3852
Carles Soriano-MasDepartment of Psychiatry, Bellvitge University Hospital. Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.ORCID 0000-0003-4574-6597
Narcís CardonerCentro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Carlos III Health Institute, Madrid, Spain.ORCID 0000-0001-9633-0888
Jeggan TiegoTurner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Melbourne, Australia.ORCID 0000-0001-7835-6398
Murat YücelTurner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Melbourne, Australia.
Leah BraganzaTurner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Melbourne, Australia.
Chao SuoTurner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Melbourne, Australia.
Michael BerkDeakin University, IMPACT - the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Geelong, Australia.
Sue CottonOrygen, Melbourne, Australia.ORCID 0000-0002-9386-8348
Mark A BellgroveTurner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Melbourne, Australia.ORCID 0000-0003-0186-8349
Andre F MarquandDonders Centre for Cognitive Neuroimaging, Radboud University, Nijmegen, the Netherlands.ORCID 0000-0001-5903-203X
Alex FornitoTurner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Melbourne, Australia.ORCID 0000-0001-9134-480X

Funding

Discovering prognostic neuroimaging biomarkers of the psychosis spectrum using network control theoryR00MH127296 · NIMH · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI PARKES, LINDEN · 2023 to 2025
$747k
NIMH NIH HHS R00 MH127296Wellcome Trust
6 · The paper itself

Abstract

Background: Inter-individual variability in neurobiological and clinical characteristics in mental illness is often overlooked by classical group-mean case-control studies. Studies using normative modelling to infer person-specific deviations of grey matter volume have indicated that group means are not representative of most individuals. The extent to which this variability is present in white matter morphometry, which is integral to brain function, remains unclear. Methods: We applied Warped Bayesian Linear Regression normative models to T1-weighted magnetic resonance imaging data and mapped inter-individual variability in person-specific white matter volume deviations in 1,294 cases (58% male) diagnosed with one of six disorders (attention-deficit/hyperactivity, autism, bipolar, major depressive, obsessive-compulsive and schizophrenia) and 1,465 matched controls (54% male) recruited across 25 scan sites. We developed a framework to characterize deviation heterogeneity at multiple spatial scales, from individual voxels, through inter-regional connections, specific brain regions, and spatially extended brain networks. Results: The specific locations of white matter volume deviations were highly heterogeneous across participants, affecting the same voxel in fewer than 8% of individuals with the same diagnosis. For autism and schizophrenia, negative deviations (i.e., areas where volume is lower than normative expectations) aggregated into common tracts, regions and large-scale networks in up to 35% of individuals. Conclusions: The prevalence of white matter volume deviations was lower than previously observed in grey matter, and the specific location of these deviations was highly heterogeneous when considering voxel-wise spatial resolution. Evidence of aggregation within common pathways and networks was apparent in schizophrenia and autism but not other disorders.

Indexed as

connectomeheterogeneityMRInormative modellingPsychiatric disorderswhite matter volume

Identifiers

PMID39149253
PMCPMC11326206

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.